THREE NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS: RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSINBIOLLAZ J; BURNIER M; TURINI GA et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 5; PP. 665-670; BIBL. 15 REF.Article

EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME INHIBITOR MK 421 AND ITS LYSINE ANALOGUE ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY SUBJECTSBRUNNER DB; DESPONDS G; BIOLLAZ J et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 5; PP. 461-467; BIBL. 13 REF.Article

URINARY RECOVERY OF N-FORMIMIDOYL THIENAMYCIN (MKO787) AS AFFECTED BY COADMINISTRATION OF N-FORMIMIDOYL THIENAMYCIN DEHYDROPEPTIDASE INHIBITORSNORRBY SR; ALESTIG K; BJORNEGARDY B et al.1983; ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; ISSN 0066-4804; USA; DA. 1983; VOL. 23; NO 2; PP. 300-307; BIBL. 3 REF.Article

PHARMACOKINETICS AND TOLERANCE OF N-FORMIMIDOYL THIENAMYCIN (MKO787) IN HUMANSNORRBY SR; ALESTIG K; FERBER F et al.1983; ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; ISSN 0066-4804; USA; DA. 1983; VOL. 23; NO 2; PP. 293-299; BIBL. 12 REF.Article

Numerical modelling of elementary failure mechanisms and associated caustics in two-phase composite structuresHERRMANN, K. P; FERBER, F.Computers & structures. 1992, Vol 44, Num 1-2, pp 41-53, issn 0045-7949Conference Paper

Bruchmechanische Untersuchungen an Matrix- und gekrümmten Grenzflächenrissen und numerische Simulation des Kaustikeneffektes = Investigation of fracture mechanics in matrix and curved surface cracks, and numerical simulation of caustic effectsFERBER, F; HERRMANN, K. P.Zeitschrift für angewandte Mathematik und Mechanik. 1991, Vol 71, Num 4, pp T279-T282, issn 0044-2267Article

Bestimmung bruchmechanischer Parameter mittels der digitalen Bildanalysetechnik und der schattenoptischen Kaustikenmethode = Determination of fracture mechanical parameters by using digital image analysis and shadow opticsFERBER, F; NOE, A; HERRMANN, K. P et al.ÖIAZ. 1996, Vol 141, Num 5, pp 203-210, issn 0721-9415Article

Zur geometrischen Form der Kaustiken gekrümmter Greenzflächenrisse = About the geometrical form of caustics of curved boundary surface cracksNOE, A; MEINERS, W; FERBER, F et al.Zeitschrift für angewandte Mathematik und Mechanik. 1991, Vol 71, Num 4, pp T319-T322, issn 0044-2267Article

Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteersROUSSO, P; BUCLIN, T; NUSSBERGER, J et al.Journal of cardiovascular pharmacology. 1998, Vol 31, Num 3, pp 408-417, issn 0160-2446Article

Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen-2)27) ratsGARDINER, S. M; KEMP, P. A; BRUNNER-FERBER, F et al.British journal of pharmacology. 1997, Vol 122, Num 8, pp 1694-1701, issn 0007-1188Article

Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious ratsGARDINER, S. M; KEMP, P. A; BRUNNER-FERBER, F et al.British journal of pharmacology. 1997, Vol 122, Num 8, pp 1687-1693, issn 0007-1188Article

Zur Stereospezifität der Augendrucksenkung eines lokal applizierten Karbonhydrasehemmers = The stereospecific potencies of intraocular pressure reduction of the topical carbonic anhydrase inhibitor MK-417DIESTERLHORST, M; BECHETOILLE, A; LIPPA, E et al.Fortschritte der Ophthalmologie. 1990, Vol 87, Num 2, pp 131-133, issn 0723-8045, 3 p.Article

Activities of human acidic fibroblast growth factor in an in vivo dermal equivalent modelDUBERTRET, L; BRUNNER-FERBER, F; MISITI, J et al.Journal of investigative dermatology. 1991, Vol 97, Num 5, pp 793-798, issn 0022-202XArticle

Lokale Karboanhydrasehemmer MK-927 und MK-417 : Wirkung und Verträglichkeit = Local carbonic anhydrase inhibitors MK-927 and MK-417 effects and toleranceGERLING, J; PFEIFFER, N; LIPPA, E et al.Fortschritte der Ophthalmologie. 1990, Vol 87, Num 6, pp 692-695, issn 0723-8045, 4 p.Article

Gekrümmte Rissausbreitung 3-Dimensionaler Rissfronten in 2-Phasen Verbunden = 3-D crack growth in two-phase compoundsLINNENBROCK, K; FERBER, F; HERRMANN, K. P et al.Zeitschrift für angewandte Mathematik und Mechanik. 2001, Vol 81, pp S857-S858, issn 0044-2267, SUP4Conference Paper

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteersROUSSO, P; BUCLIN, T; NUSSBERGER, J et al.European journal of clinical pharmacology. 2000, Vol 55, Num 10, pp 749-754, issn 0031-6970Article

Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitorLIPPA, E. A; VON DENFFER, H. A; HOFMANN, H. M et al.Archives of ophthalmology (1960). 1988, Vol 106, Num 12, pp 1694-1696, issn 0003-9950Article

Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417PFEIFFER, N; GERLING, J; LIPPA, E. A et al.Graefe's archive for clinical and experimental ophthalmology. 1991, Vol 229, Num 2, pp 111-114, issn 0721-832X, 4 p.Article

Ein neuer, lokal anwendbarer Carboanhydrasehemmer (MD-927) : Toleranzvergleich mit Betaxolol bei gesunden Probanden = A new topical carboanhydrase inhibitor (MK-927): tolerance comparison with betaxolol in normal subjectsFEICHT, B; HOFMANN, H.-M; LIPPA, E et al.Klinische Monatsblätter für Augenheilkunde. 1990, Vol 97, Num 3, pp 254-256, issn 0023-2165, 4 p.Article

Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamideBIOLLAZ, J; MUNAFO, A; BUCLIN, T et al.European journal of clinical pharmacology. 1995, Vol 47, Num 5, pp 453-460, issn 0031-6970Article

A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patientsPFEIFFER, N; HENNEKES, R; LIPPA, E. A et al.British journal of ophthalmology. 1990, Vol 74, Num 7, pp 405-408, issn 0007-1161, 4 p.Article

Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flowBIOLLAZ, J; WAEBER, B; NUSSBERGER, J et al.European journal of clinical pharmacology. 1986, Vol 31, Num 1, pp 1-8, issn 0031-6970Article

Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humansPENTIKAINEN, P. J; SARAHEIMO, M; SCHWARTZ, J. I et al.Journal of clinical pharmacology. 1992, Vol 32, Num 2, pp 136-140, issn 0091-2700Article

Assessment of systemic effects of different ophthalmic β-blockers in healthy volunteersBAUER, K; BRUNNER-FERBER, F; DISTLERATH, L. M et al.Clinical pharmacology and therapeutics. 1991, Vol 49, Num 6, pp 658-664, issn 0009-9236Article

Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjectsBUCLIN, T; BIOLLAZ, J; LIPPA, E. A et al.Clinical pharmacology and therapeutics. 1991, Vol 49, Num 6, pp 665-673, issn 0009-9236Article